Serum anti-mullerian hormone levels in the main phenotypes of polycystic ovary syndrome
Tarih
2013Yazar
Tuten, Abdullah
Aydogan, Begum
Seyisoglu, Hakan
Atakul, Nil
Oncul, Mahmut
Sahmay, Sezai
Üst veri
Tüm öğe kaydını gösterÖzet
Objective: To characterize the difference in circulating anti-Mallerian hormone (AMH) levels between the main polycystic ovary syndrome (PCOS) phenotypic groups and evaluate the role of AMH in predicting the severity of PCOS.
Koleksiyonlar
- Makale [92796]